The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Enteric Disease Testing Global Market Report 2024, the enteric disease testing market is expected to show promising growth in the forecast period.

The enteric disease testing market has witnessed robust growth in recent years, with a significant rise from $4.33 billion in 2023 to $4.59 billion in 2024, marking a compound annual growth rate (CAGR) of 5.8%. This surge can be attributed to various factors, including water and food safety concerns, increased outbreaks and epidemics, globalization of food supply, heightened travel-related infections, and evolving regulatory standards.

Projections for Future Growth
Anticipating a continued upward trajectory, the enteric disease testing market is expected to reach $5.81 billion in 2028, exhibiting a CAGR of 6.1%. The forecasted growth hinges on factors like the integration of telemedicine and remote monitoring, the impact of climate change, cross-sector collaboration, challenges posed by antimicrobial resistance, and the emergence of new enteric pathogens. Notable trends in this period include the rise of molecular diagnostics, seamless integration of digital health, the incorporation of AI and machine learning, adoption of syndromic testing, and the prevalence of point-of-care testing.

The Surge In Frozen Food Consumption Fuels Enteric Disease Testing Market Growth

Growing Consumption of Frozen Food

The burgeoning consumption of frozen food is poised to drive the growth of the enteric disease testing market. Frozen food, preserved by lowering its temperature, can become a source of foodborne illnesses, including enteric diseases, if mishandled. In 2022, frozen food sales surged by 8.6%, reaching $72.2 billion, as reported by the American Frozen Food Institute. This escalating trend highlights the need for rigorous enteric disease testing due to potential hazards associated with improper handling, storage, or cooking of frozen food products.

Key Players in the Enteric Disease Testing Market
A myriad of companies plays a pivotal role in shaping the landscape of the enteric disease testing market. Some noteworthy names include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., and many others. The competitive edge in this market is often sought through the development of products capable of concurrently measuring multiple biomarkers, thereby enhancing the diagnosis and monitoring of gastrointestinal conditions.

View More On The Enteric Disease Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Increasing Focus on Concurrent Biomarker Measurement
Major players in the market are concentrating on introducing products with the ability to simultaneously measure multiple biomarkers, aiming to gain a competitive edge. An example is the Q-Plex Human Environmental Enteric Dysfunction (11-Plex) diagnostic tool, launched by Quansys Biosciences Inc. in collaboration with PATH. This tool, capable of assessing eleven biomarkers simultaneously, aids in comprehending and tackling conditions like Environmental Enteric Dysfunction (EED) prevalent in resource-limited areas.

Noteworthy Acquisitions: Thermo Fisher Scientific and Mesa Biotech
In February 2021, Thermo Fisher Scientific made a significant move by acquiring Mesa Biotech, a point-of-care molecular diagnostic company. This strategic acquisition combines Thermo Fisher’s expertise with Mesa’s innovative platform, promising cost-efficient and optimal solutions for patients. Such acquisitions contribute to the dynamism and advancements in the enteric disease testing market.

Market Segmentation

The enteric disease testing market is segmented based on:

1. Disease Type:
   • Bacterial Enteric Disease
   • Parasitic Enteric Disease
   • Viral Enteric Disease
   • Other Disease Types
2. Technology:
   • Traditional
   • Rapid
   • Convenience-Based
   • Polymerase Chain Reaction (PCR)
   • Immunoassay
   • Chromatography And Spectrometry
   • Other Technologies
3. Application:
   • Hospitals
   • Research Centers
   • Clinics
   • Other Applications

Regional Dynamics
In 2023, North America emerged as the largest region in the enteric disease testing market. However, the forecast indicates that Europe will outpace other regions in terms of growth in the coming years.

In conclusion, the enteric disease testing market is undergoing a transformative phase, driven by a confluence of factors. The intersection of technological advancements, changing consumer behaviors, and the emphasis on comprehensive testing solutions positions the market for sustained growth and innovation.

Request A Sample Of The Global Enteric Disease Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6118&type=smp